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http://www.lipidworld.com/content/13/1/193RESEARCH Open AccessFlavonoids furom Coreopsis tinctoria adjust lipid
metabolism in hyperlipidemia animals by
down-regulating adipose differentiation-related
protein
Yali Li1†, Xinmei Chen2†, Jie Xue3, Jiangyun Liu3, Xinhua Chen4* and Muhuyati Wulasihan1*Abstract
Background: To identify the chemical structure of Coreopsis tinctoria extracts and their effect and mechanism on
reducing blood lipid in hyperlipemia mice.
Methods: The flavonoids were extracted from Coreopsis tinctoria. The chemical structure was identified by HPLC.
59 mice were divided randomly into 5 groups. (group 1: normal diet control; group 2: hyperlipemia model; group 3:
hyperlipemia mice treated with Coreopsis tinctoria, low dose 100 mg/kg; group 4: hyperlipemia mice treated with
Coreopsis tinctoria high dose group 200 mg/kg; group 5 hyperlipemia mice treated with Fenofibrate. After 2 week
of hyperlipid diet, the treatment of Coreopsis tinctoria and Fenofibrate were given for another 6 weeks with
continuous hyperlipid diet. The TC, TG, HDL, histology, adipose differentiation-related protein (ADRP) expression in
different groups were compared.
Results: Compared with normal diet group, TC, TG in hyperlipemia model group increased ( P < 0. 01). After treatment
with Coreopsis tinctoria low dose group, high dose group, TC of the hyperlipemia mice decreased (P < 0. 05) without
increasing AST, ALT and ALP. Fenofibrate can also decrease TC and TG but increase AST, ALT and ALP. Expression of
hepatic ADRP increased in hyperlipemia mice. Coreopsis tinctoria high dose group 200 mg/kg can inhibit ADRP as
Fenofibrate does.
Conclusion: The flavonoids from Coreopsis tinctoria extracts can reduce blood lipid without liver function damage,
showing better anti- hyperlipemia effect than Fenofibrate by down-regulating ADRP.
Keywords: Coreopsis tinctoria, Flavonoid, Hyperlipemia, Fenofibrate, Adipose differentiation-related protein (ADRP)Introduction
Hyperlipidemia is clinically common disease with the rapid
improvement of economy and quick changes in diet. The
incidence of hyperlipidemia is threatening people’s health.
A number of studies indicate that hyperlipidemia is an in-
dependent risk factor for stroke, coronary heart disease
and sudden cardiac death, and is closely related to the* Correspondence: xinhua_chen@zju.edu.cn; muhuyati@163.com
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unless otherwise stated.occurrence of non-alcoholic fatty liver disease [1]. Fenofi-
brate helps reduce cholesterol and triglycerides in the
blood to increase risk of atherosclerosis but the side effect
on liver function damage are not rare [2]. Therefore, effect-
ively and safe regulation of blood lipids and cholesterol is
significant for prevention and treatment. Botanicals extract
is rich of flavonoids and recent research show it plays an
important role in blood lipid adjustment [3].
Coreopsis tinctoria in Xinjiang is also known as
Xinjiang chrysanthemum in Snow Mountain [4]. It has
multiple pharmaceutical functions such as heat-clearing,
detoxifying, blood circulation promoting and blood sta-
sis removing. Local Uyghur people use it as an herb tea
to treat high blood pressure and diarrhea. Modernis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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blood sugar, blood lipid and blood pressure [5,6]. It is re-
ported that Coreopsis tinctoria in Xinjiang is rich of fla-
vonoids and can adjust glucose metabolism and reduce
cardiovascular disease risk [5,6]. There has not research
on lipid metabolism [7]. In this study we investigate its
active ingredient identification, biomedical function and
molecular mechanism on lipid metabolism.
Material and methods
Instruments
Electronic scale (Mettler-Toledo manufacturing company,
Model AL104). Homogeneous dispersion machine (Shanghai
Jinda biochemistry Instrument CO. Model FJ-200). Spec-
trophotometer (Kodak, Model 722). Visible Spectropho-
tometer (Shanghai Scientific Instrument Company, Model
722N). High lipid diet was made of lard which was
purchased commercially in local market. Cholesterol was
from HuiXing, China Biochemical Reagents LLT, analyt-
ical grade, LOT number 120312. Sucrose was provided by
the Yancheng Honey Garden Food CO, LOT number
20120915). Propyl thiouracil was provided by Shanghai
ZhaoHui Pharmaceutical, LOT number 20120206). Propyl-
ene glycol and polysorbate-80 was provided by Reed Sino-
pharm Chemical Company, analytical grade, LOT number
T20110418 and F20110726, respectively. Total cholesterol
(TC), triglyceride (TG) and high-density lipoprotein choles-
terol (HDL-c), low-density lipoprotein cholesterol (LDL-c)
and alanine aminotransferase (ALT), aspartate aminotrans-
ferase (AST), alkaline phosphatase (ALP) kits are provided
by Beijing Beihua Kangtai Clinical Reagent, LOT number:
20130717). Fenofibrate was used as a positive control and
mixed with 0.5%CMC-Na2 to make 0.2% solution. Drugs
were sealed and placed in refrigerator for the further tests.
Process of flavonoids extract
Coreopsis tinctoria were collected from Dabanchen
Xinjiang, China (LOT number 130501) and the botanical
origin of material was identified by Prof. Xinmei Chen,
College of Pharmaceutical Sciences, Shandong Traditional
Medical University, Jinan, China. Dry flowers (20 kg) were
extracted with 70% aqueous ethanol (v/v) for two times
(200 L, 1.5 h each) under reflux. After evaporation, the resi-
due was suspended in H2O (10 L) and filtrated, the liquor
solution was then subjected to AB-8 macroporous resin
column (80 × 10 cm i.d.), eluting with H2O, 20%, 70%, 95%
ethanol (each 30 L) successively. The 70% and 95% eluants
were combined and concentrated under reduced pressure
to give the total flavonoid extract (PME, 114.5 g), which
was applied to the following test in this study.
HPLC analysis
The HPLC system consisted of a two solvent delivery sys-
tem (LC-20AB), a vacuum degasser, a column thermostat(CTO-20A), a photodiode array detector and LC-Solution
(Shimadzu Corporation, Japan). Detection wavelengths
were set at 330 nm. A Cosmosil C18 AR - П column
(250 mm× 4. 6 mm, 5 μm) was used with a flow rate of
1.0 mL · min-1. The injection volume was 10 μL and the
column temperature was maintained at 35°C. An isocratic
elution was adopted with 14% acetonitrile-0.1% acetic acid
as mobile phase.
Animal experiments for hyperlipidemia animal model
A total of 59 male mice (20 ± 2 g) were acquired from
the Zhaoyan Laboratory Animal Co., Ltd. (Soochou,
China). All experiments were performed in compliance
with the Chinese Legislation on The Use And Care of
Laboratory Animals and were approved by the com-
mittee on animal care and use of Soochow University
(Laboratory animal production license: SCXK 2013–0003,
laboratory animal use license: SYXK 2012–0045). Animals
were maintained in Soochow University School of Medicine
laboratory animal Center. Room temperature 20 ± 2°C, hu-
midity 55-65%, 12 h/12 h light–dark cycle with free feeding
and drinking water.
The non-hyperlipidemia control group were given nor-
mal diet (n = 11); hyperlipidemia anima model was induced
in the mice by oral feeding of high fat diet (lard 20%, chol-
esterol 10%, bile salts 2%, Propylthiouracil 0.2%, propylene
glycol 20%, polysorbate-80 20%.0.2 mg/per 10 g weight per
day) for 2 weeks. The hyperlipidemia animal model was
confirmed by blood lipid test and then the confirmed
hyperlipidemia mice were randomly divided into 4 groups.
With continuous high fat diet, the following treatments
were administered for another 6 weeks: Hyperlipidemia
group (n = 12), the low-dose group (oral feeding of
Coreopsis tinctoria 100 mg/kg, n = 12), high-dose groups
(oral feeding of Coreopsis tinctoria 200 mg/kg, n = 12),
Fenofibrate group (oral feeding of Fenofibrate 40 mg/kg,
n = 12). After the final treatment, the mice were weighed
and then sacrificed. All liver specimens in each group were
fixed with 10% buffered formalin and embedded in paraf-
fin for slicing after weighing. Five sections in each group
were used for histopathology examination and others for
Immunohistochemical examination. Sections were stained
with hematoxylin and eosin for histopathology examin-
ation. The blood sample was taken for blood lipid and
liver function test.
Blood lipid and liver function test
The serum TG, TC, LDL, HDL, ALT, AST and ALP were
determined during the treatment period by serum TC
and TG once every 2 weeks. After final treatment, the
mice were given no food for 12 h. Blood sample was
taken from orbital vein, centrifuge 15 min in 3500 r/min
to get its serum for TC, TG, HDL, LDL, AST and ALT
measurement. After collecting blood in mice, the liver
Figure 1 HPLC/DAD analysis of extract from Xinjiang Coreopsis tinctoria. HPLC chromatographic profile of Coreopsis tinctoria extracts. (A)
Total Coreopsis tinctoria extracts from dry flower top (B) total flavonoid at 348 nm. (C) the major compound marinin at 348 nm.
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Table 1 Average food intake changes (g/mice)
Normal diet (n = 11) Hyperlipidemia (n = 12) CT 100 mg/kg (n = 12) CT 200 mg/kg (n = 12) Fenofibrate (n = 12)
High lipid diet 1 week 6.19 ± 0.46** 5.36 ± 0.22 5.30 ± 0.25 5.30 ± 0.22 5.33 ± 0.23
High lipid diet 2 weeks 6.30 ± 0.89** 4.91 ± 0.58 5.12 ± 0.55 5.06 ± 0.57 4.94 ± 0.35
Treatment 1 week 6.58 ± 1.43 5.22 ± 1.16 5.56 ± 1.19 5.25 ± 1.23 5.62 ± 1.08
Treatment 2 weeks 4.62 ± 0.18 4.61 ± 0.29 4.55 ± 0.19 4.45 ± 0.24 4.57 ± 0.26
Treatment 3 weeks 5.01 ± 0.02 4.55 ± 0.47 4.56 ± 0.28 4.20 ± 0.46 4.32 ± 0.40
Treatment 4 weeks 4.77 ± 0.22 4.30 ± 0.61 4.28 ± 0.35 4.20 ± 0.49 4.20 ± 0.33
Treatment 5 weeks 4.56 ± 0.03** 3.97 ± 0.22 4.18 ± 0.19 3.99 ± 0.19 3.99 ± 0.27
Treatment 6 weeks 4.57 ± 0.02** 3.95 ± 0.16 4.12 ± 0.23 3.94 ± 0.23 4.02 ± 0.13
**P < 0.01 vs model group.
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liver (liver weight index = hepatic mass/body mass ×100%).
The left lobe of the liver, was grounded at 3000 r/min in
centrifuge for 10 min to get the supernatant for TC, TG
measurement. The rest of hepatic tissues were snap-frozen
in liquid nitrogen and stored at −80°C for Western blot.
Morphological evaluation
Liver index was obtained by dividing liver weight by
mouse weight and then times 100%. The liver specimens
were fixed with 10% neutral formalin and embedded in
paraffin. Paraffin sections of liver were stained with H&E
for histopathological examination. Fat accumulation in
liver. Was graded according to the methods (Bujanda etal.,
2008; QinandTian, 2010)(grade0: no fat was found; grade1:
less than 33%; grade2:33–66%; grade3:more than 66% of
hepatocytes were affected by fatvacuoles).
Western blotting analysis
Hepatic tissue samples protein concentration was de-
termined using a BCA Kit (Pierce, Rockford, IL, USA).
Samples containing 50 μg of protein each were loaded on a
10% SDS-PAGE gel and then transferred to a nitrocellulose
membrane. The membrane was then rinsed and incubated
with witha1:1000 dilution of a rabbit polyclonalanti mouse
ADRP (Santa Cruz Biotechnology, California, USA) or
anti GAPDH (1:5000 dilution) (Sigma, Missouri, USA).Table 2 The average mouse weight change during the experi
Week Treatment Normal diet (n = 11) Hyperlipidemia (n = 12)
0 Begin 24.48 ± 1.80 24.03 ± 2.26
1 High lipid diet 32.69 ± 1.91 31.96 ± 2.11
2 High lipid diet 36.93 ± 1.81 35.43 ± 2.39
3 treatment 40.37 ± 1.89 38.33 ± 2.89
4 treatment 42.05 ± 2.31 39.98 ± 3.01
5 treatment 44.11 ± 2.41 43.40 ± 3.49
6 treatment 45.77 ± 2.39 44.33 ± 3.33
7 treatment 47.07 ± 2.88 45.38 ± 3.47
8 treatment 48.61 ± 3.06 46.92 ± 3.82Membranes were then washed and incubated with
horseradish-peroxidase-conjugated donkey anti-mouse
IgG at 1:5000. The ECL™ Western blotting detection re-
agent (Amersham Biosciences, New Jersey, USA) was
used for visualization and the results were analyzed
quantitatively using SigmaScan Pro 5.0. The data were
normalized with respect to ratios of GAPDH detected
on the same blot to control for variation in protein
loading across samples.
Statistical analysis
All data are expressed as means ± SD. The significance of
difference among groups was determined by using one-way
ANOVA. P < 0.05 was considered statistically significant.
Results
Identification of flavonoids in Coreopsis tinctoria
Marein, 0.8653 mg/Ml was used as standard, using HPLC/
PDA system to establish a qualitative and quantitative ana-
lysis of herbs and total flavonoids. Chromatographic con-
ditions: Shimadzu LC 20A HPLC liquid systems, Cosmosil
C18 column (4.6 × 250 mm), acetonitrile −0.1% ammo-
nium acetate (20:80) as the mobile phase, flow rate 1.0 ml/
min, injection volume 10 ul; PDA detection wavelength:
280,348 nm. The results shown in Figure 1. The HPLC
conditions chosen were adequate to separate compounds
as shown in chromatograms presented in Figure 1. Thement (g/mice)
CT 100 mg/kg (n = 12) CT 200mg/kg (n = 12) Fenofibrate (n = 12)
24.13 ± 2.12 24.21 ± 1.94 23.53 ± 2.06
32.19 ± 1.50 31.56 ± 1.41 32.10 ± 1.88
36.22 ± 2.02 35.11 ± 2.46 35.81 ± 2.75
39.06 ± 2.11 38.16 ± 2.11 37.94 ± 3.35
40.61 ± 2.45 39.45 ± 1.82 39.82 ± 3.47
43.10 ± 2.85 42.42 ± 2.22 42.03 ± 4.05
43.87 ± 2.53 43.71 ± 2.22 43.07 ± 4.35
45.66 ± 2.79 44.97 ± 2.37 44.22 ± 4.17
47.31 ± 3.02 46.83 ± 2.47 46.16 ± 4.77
Table 3 The blood lipid levels at 2 weeks and 4 weeks after drug administration
n TC (mmol/L) TG (mmol/L)
2 week 4 week 2 week 4 week
Normal diet 11 3.4 ± 0.43** 3.28 ± 0.39** 1.56 ± 0.38** 2.19 ± 0.54*
Model 12 4.75 ± 0.69 4.53 ± 0.60 2.96 ± 0.96 2.83 ± 0.76
CT100mg/kg 12 4.39 ± 0.63 4.14 ± 0.48 2.24 ± 0.91 2.04 ± 0.68*
CT 200 mg/kg 12 4.29 ± 0.48 4.02 ± 0.38* 2.12 ± 0.55* 2.18 ± 0.68 *
Fenofibrate 12 4.05 ± 0.84* 3.70 ± 0.68** 2.72 ± 0.97 2.23 ± 0.48*
Compared with hyperlipidemia model,*P < 0.05;**P < 0.01.
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tron spray ionization (ESI) mass spectrometry provided
chemical composition of the fraction and they were
mainly aglycones and glycosides of flavanone/chalcone
flavonoid type. Compound marein appears as the major
peak detected. The major 12 compounds seperated from
LC/PDA/ESIMS chromatogram include 3,4’,5,6,7-Penta-
hydroxyflavanone-O-hexoside, Chlorogenic Acid, Flavano-
marein, Flavanokanin, Quercetagitin-7-O-glucoside, 3,4’,
5,6,7-Pentahydroxyflavanone, 3’,5,5’,7-Tetrahydroxyfla-
vanone-O-hexoside, Marein, 3’,5,5’,7-Tetrahydroxy fla-
vanone Okanin, Dicaffeoylquinic acid, Coreopsin.
The changes in food intake and body weight in mice
Hyperlipidemia mice model intake less food than that in
the control group (P < 0.01). Hyperlipidemia mice lost
slight weight but showed no significant difference com-
pared with control group. Throughout the experimental
period, Xinjiang Coreopsis tinctoria groups showed no
significant difference in food taking and body weight
compared with hyperlipidemia model group, indicating
that total flavonoids from Xinjiang Coreopsis tinctoria
has no apparent adverse effects or acute toxicity on
mice. The changes in food intake were shown in Table 1
and body weight shown in Table 2.
Mouse serum TG, TC, HDL, LDL change
The results are shown in Tables 3 and 4. Throughout the
experimental period, TC and TG level in the hyperlipid-
emia mice are significantly higher than normal diet group
(P < 0.05 or P < 0.01), indicating the success of the hyper-
lipidemia model. The total flavonoids from Coreopsis tinc-
toria extract decreased serum TC and TG 4 weeks afterTable 4 The blood lipid levels at 6 weeks after drug administ
n TC (mmol/L) T
Normal diet 11 3.27 ± 0.34**
Model 12 4.17 ± 0.70
CT 100 mg/kg 12 3.91 ± 0.45
CT 200 mg/kg 12 3.88 ± 0.47
Fenofibrate 12 3.62 ± 0.62*
Compared with hyperlipidemia control ,*P < 0.05; **P < 0.01.drug administration. The total flavonoids from Coreopsis
tinctoria extract have no obvious impact on HDL and
LDL or other adverse effects. The serum TC and TG in
Fenofibrate group decreased (P < 0.05), showing no statis-
tically significant differences in HDL levels or LDL.The mouse liver weight, liver weight index, liver TC and TG
The liver TC and TG in the hyperlipidemia model, the
liver weight, liver weight index were significantly higher
than the control group (P < 0.01) as shown in Table 5.
At 6 weeks, total flavonoids from plant extract groups
liver TC and liver weight index decreased (P < 0.05 or
P < 0.01). Liver TG and liver weight showed no statistically
significance. Fenofibrate group decreased TC (P < 0.01),
but increased liver weight index and liver weight signifi-
cantly (P < 0.01), no statistically significant changes in liver
TG. The results are shown in Table 5.Effects of Coreopsis tinctoria on histopathological
changes of livers
Photomicrographs of hepatic specimens stained with
H&E were shown in Figure 2. In normal diet group, the
livers showed the normal lobular structure with central
veins and radiating hepatic cords, no obvious lipid de-
position was found. Model fed with hyperlipid diet for
8 weeks developed a higher degree of steatosis,mostly
classified as macrovesicular, with a mean grade more
than 2. In CT100 mg/kg, CT200mg/kg and Fenofibrate
groups, much smaller microvesicular steatosis was seen
in Figure 2. The groups had much less and lower size
vacuoles compared with the model group (Figure 2). Re-
sults showed that hepatic ADRP protein expressionsration
G (mmol/L) HDL (mmol/L) LDL (mmol/L)
1.65 ± 0.27** 2.52 ± 0.21 0.05 ± 0.06*
2.69 ± 1.15 2.67 ± 0.34 0.43 ± 0.45
1.66 ± 0.55* 2.48 ± 0.19 0.67 ± 0.27
1.54 ± 0.48** 2.40 ± 0.17* 0.78 ± 0.30
1.92 ± 0.42* 2.51 ± 0.26 0.25 ± 0.15
Table 5 Liver TG, Liver weight and liver weight index at 6 weeks after drug administration
n TC (mg/g wet tissue) TG (mg/g wet tissue) Liver weight (g) liver weight index g/100 g weight)
Normal diet 11 7.08 ± 0.48** 29.08 ± 5.73** 1.80 ± 0.16** 3.72 ± 0.31**
Model 12 16.33 ± 5.47 76.88 ± 20.04 2.46 ± 0.27 5.24 ± 0.33
CT 100 mg/kg 12 11.61 ± 1.39** 63.67 ± 9.59 2.30 ± 0.30 4.86 ± 0.46*
CT 200 mg/kg 12 12.53 ± 1.84* 66.31 ± 11.51 2.31 ± 0.22 4.96 ± 0.35*
Fenofibrate 12 11.30 ± 1.72** 77.43 ± 11.48 4.21 ± 0.64** 9.12 ± 0.93**
Compared with hyperlipidemia model,*P < 0.05;**P < 0.01.
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Figure 3.
ALT and AST are the marker of liver function. In the
hyperlipidemia mice group, ALT, AST and ALP showed
no significant increase seen in Table 6. After given low
and high dose flavonoids from Coreopsis tinctoria extract,
the ALT, AST and ALP did not change significantly either.
Wihile in Fenofibrate group ALT, AST, ALP increased
significantly (ALT, AST, P < 0.05; ALP, P < 0.01) (seen in
Table 6).
Discussion
In this study we investigate the active ingredient identifi-
cation, biomedical function and molecular mechanism
of Coreopsis tinctoria on lipid. An efficient method for
enrichment of flavonoids from the flowers of Coreopsis
tinctoria was developed using macroporous resin. HPLC
proved that flavonoids are functional ingredients abundant
in Coreopsis tinctoria. Flavonoids reduce TC and TG level
in hyperlipidemiaadipose mice by down regulating adipose
differentiation-related protein (ADRP) expression.
Flavonoids are polyphenolic compounds produced by
plants and proved effective in prevention of cardiovascular,Figure 2 Histopathological changes of rat liver in different groups (H
Normal diet group; Model group; CT 100mg/kg group; CT 200mg/kg group
Each group consisted of 11-12 mice. Values are given as means±SEM. treatcarcinogenic, neurodegenerative and immune diseases.
Here we investigate its effect on modulating the lipid me-
tabolism. Hyperlipidemia is a lipid metabolic disease due
to abnormal fat metabolism [8]. In this study, we use high
fat diet by intragastric administration to set up a hyperlip-
idemia model in mice. The serum TC and TG, LDL levels
were higher than those in the control group (P < 0.05,
P < 0.01), indicating successful establishment of mouse
model of hyperlipidemia. Treatment with flavonoids from
Coreopsis tinctoria of low and high dose groups can de-
crease serum TG in hyperlipidemia animal, and there is a
clear dose–response relationship.
Studies have shown that lipid metabolism disorder and
insulin resistance lead to liver lipid and triglycerides pro-
duction increased, exceeding its transfer capacity, causing
lipid accumulation in liver, or even liver damage [9]. The
results of this study showed in the liver tissue of hyperlip-
idemia mouse model, the TC, TG, liver weight and liver
weight index were higher than those in the control group.
Compare with hyperlipidemia model, the low and high
dose of total flavonoids can decrease the TC and liver
weight indexes, indicating that total flavonoids from Core-
opsis tinctoria extract can not only reduce blood fat, butE stained200X upper and 400X lower). (A) five different treatments:
; Fenofibrate group; and (B) Pathological grading of hepatic steatosis.
ment vs. normal group; *p < 0:05, **p < 0:01 vs. Model group.
Figure 3 Western blotting for ADRP expression in livers. Representative Western blot of ADRP (A) as well as quantitative analysis of blots (B).
ADRP protein level corrected by GAPDH. Data are presented as mean _ SEM. *p < 0:05, **p < 0:01 vs. Normal group.
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are chemical drugs for hyperlipidemia treatment among
which Fenofibrate is a commonly used medicine. The long
time use of Fenofibrate caused side effects such as liver
damage and muscle breakdown [10]. In the Fenofibrate
group the mice serum TC and liver tissue TG decrease,
serum LDL also decreased, but it increased ALP, ALT and
AST.
ALT and AST are the main index reflecting liver func-
tion status. ALT exists in the liver cells, AST exists in
mitochondrial and cytosolic. Alkaline phosphatase ALP is
widely distributed in many organs such as the liver, bones,
intestines, kidneys and the placenta. Enzymes in the liver
cells and liver sinusoids have a concentration gradient. InTable 6 AST, ALT and ALP at 6 weeks after drug
administration
n ALT (u/L) AST (u/L) ALP (u/L)
Normal diet 11 51.88 ± 17.99 113.87 ± 6.12 101.28 ± 2.91
Model 12 53.28 ± 12.12 93.72 ± 6.44 105.27 ± 3.12
CT 100 mg/kg 12 54.12 ± 13.74 103.45 ± 7.32 102.12 ± 3.22
CT 200 mg/kg 12 61.24 ± 19.82 121 ± 8.91 104.21 ± 2.87
Fenofibrate 12 78.87 ± 18.12* 131.49 ± 6.21* 412.21 ± 21.2**
Compared with normal diet control,*P < 0.05;**P < 0.01.the case of oxidative injury, liver cell membranes were
attacked by free radical and the permeability changes,
leading to markedly elevated serum ALT, ALP with the in-
volvement of mitochondria, the endoplasmic reticulum
membrane system [11]. However the hyperlipidemia mice
showed no ALT, AST or ALP increase, indicating the
hyperlipemia is not high enough to cause changes in ALT,
AST and ALP. The low and high dose groups of using
total flavonoids from Coreopsis tinctoria extract, the ALT,
AST and ALP do not change significantly. As a compari-
son, Fenofibrate group had significant ALT, AST, ALP in-
crease, suggesting that Fenofibrate has damage in liver
function. The total flavonoids of Coreopsis tinctoria ex-
tracts of liver damage has less impact on liver function.
Western-blot showed that adipose differentiation-related
protein (ADRP) protein expression was higher in model
model group. ADRP is expressed in the liver and its ex-
pression increases in the early stage of adipose differenti-
ation or lipid accumulation in hepatocytes [12]. ADRP
causes expansion of the number and size of lipid droplets
in the liver, which results in lipid accumulation and insulin
signaling inhibition. ADRP absence prevented the devel-
opment of alcoholic fatty liver, associated with a reduction
in the levels of triglycerides in the liver. The level of ADRP
protein expression is a reliable marker for liver steatosis
[12]. The present results showed that hepatic ADRP
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groups as seen in Figure 3.
Coreopsis tinctoria Nutt.have been used traditionally in
Portugal to control hyperglycaemia and a study revealed
that daily administration of Coreopsis tinctoria Nutt pro-
moted the recovery of glucose tolerance by inhibition of
glucose absorption and direct promotion of insulin secre-
tion. Dias T et al. [5] found that the bioactivity of several
flavonoids in Coreopsis tinctoria extracts promote pancre-
atic cell function recovery through a mechanism of action
other than merely antioxidant mediated. Our result con-
firmed that flavonoids in Coreopsis tinctoria Nutt work as
bioactive metabolites with antihyperglycaemic and antihy-
perlipemia function.
Conclusion
In summary, flavonoids from Coreopsis tinctoria extracts
showed anti- hyperlipidemia effect, particularly in lowering
triglycerides, reducing lipid deposition and protecting the
liver function. The mechanism of protective effects on hep-
atic steatosis and liver functions is associated with regulat-
ing lipid metabolism through down-regulating blood fat
via suppression ADRP expression. The experimental re-
sults provide the biomedical experiment basis for using
total flavonoids from Coreopsis tinctoria extract to treat
hyperlipidemia.
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